SEARCH

Current Edition

news

Bristol Myers finally wins FDA approval for cancer cell therapy

Dive Brief: The Food and Drug Administration on Friday approved Breyanzi, a cancer cell therapy from Bristol Myers Squibb, for the treatment of late-stage lymphoma. …

Continue Reading →
Uncategorised

Arrowhead shares soar on liver disease data from four patients

Shares in Arrowhead Pharmaceuticals rose by nearly 50% Wednesday after the California-based biotech said its drug for a rare liver disease reduced levels of a …

Continue Reading →
news

Product characterization: Reveal your molecule earlier, faster, and with accuracy

Product characterization can be challenging throughout drug development because it requires advanced technologies and specialized expertise. Thus, it is vital to start product characterization early …

Continue Reading →
news

Former FDA chief Gottlieb predicts Trump-pitched pricing model easy to game

As President Donald Trump’s International Pricing Index slogs through the regulatory process, former Food and Drug Administration head Scott Gottlieb predicted Monday it will be …

Continue Reading →
news

With new report, ICER puts itself at center of drug pricing storm

Pharmaceutical companies often preach value. Yet, for seven top-selling drugs, prices went up in 2017 and 2018 despite limited new evidence showing patients receiving treatment …

Continue Reading →
news

MilliporeSigma Acquires FloDesign Sonics for Acoustic Technology for Cell Therapy

MilliporeSigma announced it has acquired FloDesign Sonics, a Wilbraham, MA-based acoustic cell processing platform developer for the industrialization of cell and gene therapy manufacturing. MilliporeSigma …

Continue Reading →
news

Gene therapy biotechs caught in manufacturing crunch

Rapidly progressing gene therapy development could push more biotechs to invest in their own manufacturing capabilities over outsourcing to contract services companies, particularly as the …

Continue Reading →
news

Treatment of pain and inflammation with Tetra Bio-Pharma’s CAUMZ kit

CAUMZ is a non-opioid alternative in Phase 3 development for the treatment of pain and inflammation, and Tetra are one step closer to bringing the …

Continue Reading →
news

Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical Officer

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced today that …

Continue Reading →
news

Over 80 Iconic Landmarks to Light Up in Unity Across the Globe to Raise Awareness for Stage IV Metastatic Breast Cancer in October

 Moore Fight Moore Strong (MFMS) – an organization with a mission to carry on the legacy of their best friend, Jessica Moore, to raise awareness for Metastatic Breast …

Continue Reading →
news

Biogen’s R&D head is out, following string of clinical setbacks

Biogen has a new R&D leader, announcing Tuesday that Michael Ehlers will leave on Oct. 11 and, effective immediately, pass his duties on to Chief …

Continue Reading →
news

Ebola vaccine from Merck takes step toward US approval

An experimental Ebola vaccine has moved a step closer toward U.S. approval, following the Food and Drug Administration’s acceptance of an application from Merck & …

Continue Reading →
Uncategorised

Prevention studies next big test for Alzheimer’s research

A study set to read out early next year could be the final curtain for an Alzheimer’s disease hypothesis that has prevailed for more than …

Continue Reading →
news

Gene editing companies oppose altering of embryos

Dive Brief: Thirteen biopharma companies, including Sangamo Therapeutics and Bluebird bio, signed a statement of principles opposing gene editing of human sperm, eggs or embryos because of …

Continue Reading →
Uncategorised

Cancer cells are quick-change artists adapting to their environment

Until now, researchers have assumed that the growth of solid tumors originates from cancer stem cells characterized by specific surface markers, which develop in a …

Continue Reading →
news

Mice study shows antibiotics are not always necessary to cure sepsis

Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure …

Continue Reading →
news

This RNA-based technique could make gene therapy more effective

Delivering functional genes into cells to replace mutated genes, an approach known as gene therapy, holds potential for treating many types of diseases. The earliest …

Continue Reading →
news

Apceth to Manufacture First Potential One-Time Gene Therapy for Transfusion-Dependent β-Thalassemia

Munich, Germany,  October 05, 2018 / B3C newswire / — apceth Biopharma GmbH, a leading company for the development and manufacturing of cell and gene therapeutics, congratulates its …

Continue Reading →
news

PCI and CSP Technologies, Inc. Announce Strategic Collaboration for Breakthrough Activ-BlisterTM Solutions

In scavenging for undesired moisture and gases, protective packaging solution enables enhanced shelf life and speed-to-market for pharmaceutical and medical device products With more than …

Continue Reading →
news

Trial Launched to Treat Parkinson’s with Reprogrammed Stem Cells

Surgeons will inject approximately 5 million dopamine-producing progenitor cells into patients’ brains. Using cancer to fight cancer might seem counterintuitive, but there’s method to the …

Continue Reading →